To evaluate the bioequivalence of a generic three-drug FDC formulation ( 3FDC ) in comparison with a 3FDC reference with doses of 300 mg INH in 20 healthy Mexican adults , and to generate data regarding the oral relative bioavailability of the drug in this population .